Peripherally-driven myeloid NFkB and IFN/ISG responses predict malignancy risk, survival, and immunotherapy regime in ovarian cancer

oleh: Antonia Carla Testa, Sabine Tejpar, Ignace Vergote, Valentina Chiappa, An Coosemans, Thaïs Baert, Chiara Landolfo, Wouter Froyman, Dirk Timmerman, Tom Bourne, Abhishek D Garg, Patrizia Agostinis, Louis Boon, Daniela Fischerova, Caroline Van Holsbeke, Jenny Sprooten, Ann Vankerckhoven, Isaure Vanmeerbeek, Daniel M Borras, Yani Berckmans, Roxanne Wouters, Raquel S Laureano, Dominique Schols

Format: Article
Diterbitkan: BMJ Publishing Group 2021-11-01

Deskripsi

No description available for this item.